Copyright
©The Author(s) 2016.
World J Gastroenterol. May 14, 2016; 22(18): 4484-4500
Published online May 14, 2016. doi: 10.3748/wjg.v22.i18.4484
Published online May 14, 2016. doi: 10.3748/wjg.v22.i18.4484
Figure 1 Therapeutic effects of diarylpropionitrile on hepatic fibrosis in CCl4-treated rats.
Histological images of rat livers stained with HE (A) or Masson’s staining (B) (magnification × 100) and semi-quantitative measurement of Masson’s staining (C). aP < 0.05 vs control group; cP < 0.05 vs DPN group. DPN: Diarylpropionitrile.
- Citation: Zhang CG, Zhang B, Deng WS, Duan M, Chen W, Wu ZY. Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis. World J Gastroenterol 2016; 22(18): 4484-4500
- URL: https://www.wjgnet.com/1007-9327/full/v22/i18/4484.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i18.4484